脂复杂配方技术用于改善瘤环境中的药物输送:综合性审查
Jayesh Patil1, Datta Maroti Pawde1, Sankha Bhattacharya2
1Department of Pharmaceutics, School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-Be University, Shirpur, Maharashtra, 425405, India.
AAPS PharmSciTech
|April 25, 2024
概括
脂复合物配方技术通过提高溶解性和透性来提高药物的生物可用性. 这种方法为药物输送提供了一个无毒的,可生物降解的解决方案,特别是在癌症治疗中.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 溶解性和透性差,限制了许多合成药物和天然化合物的生物可用性.
- 开发有效的药物输送系统对于提高治疗疗效至关重要.
- 脂,作为内源性分子,为克服这些局限性提供了一个有希望的平台.
研究的目的:
- 审查脂复合物配方技术在改善药物生物可用性方面的潜力.
- 探索脂复合体在药物输送中的机制,配方策略和应用.
- 突出临床研究和与药物脂化合物相关的专利方面的进展.
主要方法:
- 综合文献综述,重点关注脂复合物配方.
- 详细检查溶剂蒸发方法,以创建脂复合物.
- 对配方参数的分析,包括药物与脂的比例和溶剂的选择.
- 讨论用于评估结构和功能性质的表征技术.
- 探索将脂复合物纳入纳米配方和乳液系统.
主要成果:
- 脂复合改善了药物的溶解性和透性,从而提高了生物可用性.
- 溶剂蒸发方法是脂复合物制备的一个关键技术.
- 描述证实了复合体的结构完整性和功能属性.
- 脂复合物可以集成到各种纳米配方和乳液中,以提供有针对性的输送.
- 在临床前模型中证明了各种癌症的疗效,包括乳腺,肝脏,肺部,宫和胰腺癌.
结论:
- 脂复合技术提供了一种可行的,无毒的,可生物降解的方法来提高药物输送和生物可用性.
- 这项技术在改善各种恶性瘤的癌症治疗结果方面显示出显著的前景.
- 进一步的临床研究和专利进展强调了药物脂化合物的转化潜力.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.3K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.3K


